Doyle Mittie

Chief Medical Officer at AVTX

Sold, on record
$3M
Dollars the filings state
Form 4 sales
12
Latest Aug 28, 2026
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AVTXAvalo Therapeutics, Inc.Chief Medical Officer

Sales by reason

11
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AVTXRoutine
    Jun 23, 2026 2026

    Sold 1,450 shares at $18.00 ($26k)

    Doyle Mittie, Chief Medical Officer

    10b5-1 planSold 2.7% of holdings ($958k position)51,776 shares left0.4x usual sizeFollows a Form 144Filing

  2. 2 Form 4 sale AVTXRoutine
    Jun 30, 2026 +7 days

    Sold 4,654 shares at $20.00 ($93k)

    Doyle Mittie, Chief Medical Officer

    10b5-1 planSold 8.2% of holdings ($1.1M position)51,776 shares left1.6x usual sizeFollows a Form 144Filing

  3. 3 Form 4 sale AVTXRoutine
    Jul 27, 2026 +27 days

    Sold 1,000 shares at $20.00 ($20k)

    Doyle Mittie, Chief Medical Officer

    10b5-1 planSold 1.9% of holdings ($1.1M position)51,776 shares left0.3x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice AVTXNotice
    Aug 10, 2026 +14 days

    Filed to sell 679 shares ($12k)

    Doyle Mittie, Officer

    10b5-1 plan0.2x usual sizeFiling

  5. 5 Form 4 sale AVTXRoutine
    Aug 10, 2026 same day

    Sold 679 shares at $20.00 ($14k)

    Doyle Mittie, Chief Medical Officer

    10b5-1 planSold 1.3% of holdings ($1M position)51,776 shares left0.2x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice AVTXNotice
    Aug 17, 2026 +7 days

    Filed to sell 5,037 shares ($99k)

    Doyle Mittie, Officer

    10b5-1 plan2.3x usual sizeFiling

  7. 7 Form 4 sale AVTXRoutine
    Aug 17, 2026 same day

    Sold 1,000 shares at $20.00 ($20k)

    Doyle Mittie, Chief Medical Officer

    10b5-1 planSold 1.9% of holdings ($1.1M position)51,776 shares left0.4x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale AVTXRoutine
    Aug 28, 2026 +11 days

    Sold 679 shares at $20.00 ($14k)

    Doyle Mittie, Chief Medical Officer

    10b5-1 planSold 1.3% of holdings ($1M position)51,776 shares left0.5x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Doyle Mittie
Source
Aug 28, 2026Sep 1, 2026AVTXChief Medical OfficerForm 4 sale679$14k1.3%RoutineSEC
Aug 17, 2026Aug 19, 2026AVTXChief Medical OfficerForm 4 sale1,000$20k1.9%RoutineSEC
Aug 17, 2026Aug 17, 2026AVTXOfficerForm 144 notice5,037$99kNoticeSEC
Aug 10, 2026Aug 12, 2026AVTXChief Medical OfficerForm 4 sale679$14k1.3%RoutineSEC
Aug 10, 2026Aug 10, 2026AVTXOfficerForm 144 notice679$12kNoticeSEC
Jul 27, 2026Jul 29, 2026AVTXChief Medical OfficerForm 4 sale1,000$20k1.9%RoutineSEC
Jun 30, 2026Jul 2, 2026AVTXChief Medical OfficerForm 4 sale4,654$93k8.2%RoutineSEC
Jun 23, 2026Jun 25, 2026AVTXChief Medical OfficerForm 4 sale1,450$26k2.7%RoutineSEC
May 28, 2026Jun 1, 2026AVTXChief Medical OfficerForm 4 sale679$11k1.4%RoutineSEC
May 15, 2026May 19, 2026AVTXChief Medical OfficerForm 4 sale3,000$56k45.3%RoutineSEC
May 6, 2026May 7, 2026AVTXChief Medical OfficerForm 4 sale108,234$2.2M96.8%UnusualSEC
May 6, 2026May 6, 2026AVTXOfficerForm 144 notice54,508$886kNoticeSEC
Apr 6, 2026Apr 8, 2026AVTXChief Medical OfficerForm 4 sale3,970$71k52.3%RoutineSEC
Apr 6, 2026Apr 6, 2026AVTXOfficerForm 144 notice65,800$1.2MNoticeSEC
Apr 1, 2026Apr 3, 2026AVTXChief Medical OfficerForm 4 sale679$11k15.8%RoutineSEC
Mar 16, 2026Mar 18, 2026AVTXChief Medical OfficerForm 4 sale25,492$412k87.6%RoutineSEC
Mar 16, 2026Mar 16, 2026AVTXOfficerForm 144 notice29,529$467kNoticeSEC